Skip to content
10-Q

Quarterly Report

Zyla Life Sciences

0001558370-20-006622

← back to feed
Filed
May 14, 2020 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q1 2020 · May 10, 2020 9.61M sh
Capex Q1 2020 · Mar 31, 2020 $3K
Capex Q1 2020 · Mar 31, 2019 $6K
Operating Cash Flow Q1 2020 · Mar 31, 2020 $5.33M
Operating Cash Flow Q1 2020 · Mar 31, 2019 −$16.4M
Operating Cash Flow Q1 2020 · Jan 31, 2019 $822K
Long Term Debt Q1 2020 · Mar 31, 2020 $95.48M
Long Term Debt Q1 2020 · Dec 31, 2019 $95.76M
Short Term Debt Q1 2020 · Mar 31, 2020 $7.8M
Short Term Debt Q1 2020 · Dec 31, 2019 $8.18M
Short Term Debt Q1 2020 · Feb 1, 2019 $1.49M
Cash And Equivalents Q1 2020 · Mar 31, 2020 $14.54M
Cash And Equivalents Q1 2020 · Dec 31, 2019 $11.97M
Cash And Equivalents Q1 2020 · Feb 1, 2019 $17.05M
Cash And Equivalents restated Q1 2020 · Jan 31, 2019 $36.79M
Stockholders Equity Q1 2020 · Mar 31, 2020 $24.7M
Stockholders Equity Q1 2020 · Dec 31, 2019 $42.39M
Stockholders Equity Q1 2020 · Mar 31, 2019 $76.51M
Stockholders Equity Q1 2020 · Feb 1, 2019 $86.94M
Stockholders Equity restated Q1 2020 · Jan 31, 2019 −$117.99M
Stockholders Equity Q1 2020 · Dec 31, 2018 −$111.36M
Current Liabilities Q1 2020 · Mar 31, 2020 $93.04M
Current Liabilities Q1 2020 · Dec 31, 2019 $75.77M
Current Liabilities Q1 2020 · Feb 1, 2019 $58.86M
Current Liabilities restated Q1 2020 · Jan 31, 2019 $37.54M
Current Assets Q1 2020 · Mar 31, 2020 $60.21M
Current Assets Q1 2020 · Dec 31, 2019 $51.63M
Current Assets Q1 2020 · Feb 1, 2019 $64.1M
Current Assets restated Q1 2020 · Jan 31, 2019 $50.85M
Total Assets Q1 2020 · Mar 31, 2020 $229.48M
Total Assets Q1 2020 · Dec 31, 2019 $230.39M
Total Assets Q1 2020 · Feb 1, 2019 $254.15M
Total Assets restated Q1 2020 · Jan 31, 2019 $59.92M
Sga Expense Q1 2020 · Mar 31, 2020 $7.47M
Sga Expense Q1 2020 · Mar 31, 2019 $3.37M
Sga Expense Q1 2020 · Jan 31, 2019 $5.41M
Net Income Q1 2020 · Mar 31, 2020 −$18.24M
Net Income Q1 2020 · Mar 31, 2019 −$10.48M
Net Income Q1 2020 · Jan 31, 2019 $107.24M
Operating Income Q1 2020 · Mar 31, 2020 −$14.44M
Operating Income Q1 2020 · Mar 31, 2019 −$7.68M
Operating Income Q1 2020 · Jan 31, 2019 −$8.12M
Revenue Q1 2020 · Mar 31, 2020 $19.07M
Revenue Q1 2020 · Mar 31, 2019 $15.81M
Revenue Q1 2020 · Jan 31, 2019 $1.78M
Rd Expense Q1 2020 · Mar 31, 2019 $5K
Rd Expense Q1 2020 · Jan 31, 2019 $186K